Drug product
BREXAFEMME (Ibrexafungerp) tablets 150 mg, 4 count cartons, Rx Only, Manufactured for and distributed by SCYNEXIS, Inc., Jersey City, NJ 07302 NDC 75788-115-04
D-0042-2024
Product summary
- Firm
- Scynexis, Inc.
- Event
- Event 93113
- Status
- Completed
- Classification
- Class I
- Quantity
- 17,376
- Official record key
drug-enforcement:D-0042-2024
Official wording
Reason: Cross Contamination with Other Products: Potential cross-contamination of ibrexafungerp citrate drug substance with ezetimibe (a non-antibacterial beta-lactam compound).
Code information: Lot# LF21000008, Exp. 11/30/2023 Lot# LF22000051, Exp. 11/30/2025
Distribution pattern: Nationwide in the US.
Derived failure modes
-
Unknown
Cross Contamination with Other Products: Potential cross-contamination of ibrexafungerp citrate drug substance with ezetimibe (a non-antibacterial beta-lactam compound).